New longitudinal research shows that Alzheimers disease blood biomarkers rise up to 95 percent faster in people with obesity than in those without. While baseline tests initially appeared lower due to blood dilution, long-term tracking revealed a significantly accelerated buildup of neurodegeneration and amyloid pathology.
New longitudinal research shows that Alzheimers disease blood biomarkers rise up to 95 percent faster in people with obesity than in those without. While baseline tests initially appeared lower due to blood dilution, long-term tracking revealed a significantly accelerated buildup of neurodegeneration and amyloid pathology.
Share this Article
Recommended